300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
InsurTech
Travel
Platforms
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Mobile Apps
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Wine and Spirits
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Food and Beverage
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Publishing
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Mexico
Taiwan
Tunisia
Sweden
Nigeria
Zimbabwe
Zambia
Norway
Russian Federation
Tajikistan
Togo
Guinea
Iran
Nepal
Isle of Man
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Morocco
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Canada
Malaysia
Portugal
Philippines
United Kingdom
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Bangladesh
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Sergey Jakimov, Co-Founder at Longevity Science Foundation

Sergey Jakimov

Co-Founder @ Longevity Science Foundation

Sergey Jakimov is a seed investor at Longevity Science Foundation focused on Health Care and Life Science. Serial entrepreneur, having co-founded 3 deep-tech ventures and raised more than $50 million in venture funding for his own ventures and as an entrepreneur in residence. He has worked with several other early-stage companies in the therapeutics space on fundraising, IP protection, and clinical trial strategies, focusing on early treatments incardiovascular, oncology, and neurodegenerative spaces. Visiting Lecturer to several universities on VC and intellectual property rights, co-authored a master's program in Technology Law for the Riga Graduate School of Law.

Total investments:
3
Last investment:
Lead investor:
33%

Last updated:

Industries Sergey Jakimov invests in

Health CareLife ScienceTherapeuticsBiotechnologyWellness

Stages Sergey Jakimov invests in

Seed

Countries Sergey Jakimov invests in

SwitzerlandUnited StatesUnited Kingdom

Investment Focus

Industry

  • Health Care 2 (67%)
  • Life Science 2 (67%)
  • Therapeutics 2 (67%)
  • Biotechnology 2 (67%)
  • Wellness 1 (33%)

Country

  • Switzerland 1 (33%)
  • United States 1 (33%)
  • United Kingdom 1 (33%)

Investments

CompanyDescriptionRoundLinks
Valink Therapeutics Valink Therapeutics
Valink Therapeutics is a health care drug discovery for next-generation cancer treatments. $11.8M / Seed / Oct 20, 2025
Catena Biosciences Catena Biosciences
Catena Biosciences is a biotechnology company that offers protein conjugation, building biologic structures, and medical research. $2.4M / Seed / May 10, 2024
PreComb PreComb
PreComb develops technologies to optimally adapt the therapies to each patient for difficult to treat cancers to increase the success rates in cancer therapy. Only an efficient use of healthcare resources can lead to a maximum improvement in the quality of life of patients. $1.3M / Seed / Oct 04, 2022

Co-Investors

Longevity Science Foundation

About Longevity Science Foundation

VC Fund

Longevity Science Foundation Contacts

NameEmailPhoneSocials
Sergey Jakimov
Sergey Jakimov Co-Founder
Garri Zmudze
Garri Zmudze Executive Coordinator

Sign up to unlock verified contacts

Unlock Contacts

3 more contacts available

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
InsurTech
Travel
Platforms
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Payments
Email
CleanTech
Energy
Marketplace
Organic Food
Fitness
Machine Learning
Health Care
Agriculture (AgTech)
Gaming
Facebook
Blockchain
Social Network
B2B
Video Games
Big Data
Medical Device
Wellness
Education
Mobile
Automotive
Sports
Legal
eSports
Construction
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Web3
Venture Capital
Fashion
Social
Beauty
Infrastructure
Cannabis
LGBT
Celebrity
Mobile Apps
Climate
Music
Art
Life Science
Real Estate
Sporting Goods
Manufacturing
Digital Media
FinTech
Finance
Financial Services
Wine and Spirits
Social Media
Franchise
Mobile Advertising
Non Profit
Internet
Android
Sustainability
Hardware
Biotech
Impact
Food and Beverage
Proptech
Transportation
Enterprise
Community
Media (Entertainment)
Publishing
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Oceania
Gibraltar
Liberia
Mexico
Taiwan
Tunisia
Sweden
Nigeria
Zimbabwe
Zambia
Norway
Russian Federation
Tajikistan
Togo
Guinea
Iran
Nepal
Isle of Man
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Andorra
Cameroon
Guernsey
Sudan
Colombia
Armenia
China
Costa Rica
Czech Republic
Kenya
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Kazakhstan
Morocco
Cayman Islands
Venezuela
Malawi
Myanmar
Uganda
Turkey
Uruguay
Paraguay
Moldova
Seychelles
Botswana
Ireland
Japan
South Africa
France
Georgia
Denmark
Ghana
Iraq
Mali
Latvia
Canada
Malaysia
Portugal
Philippines
United Kingdom
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Faroe Islands
Estonia
Jersey
Bahrain
Bolivia
Algeria
Belize
Finland
Italy
Belarus
Hungary
Grenada
Israel
Bangladesh
Iceland
Cambodia
Honduras
Lithuania
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Sergey Jakimov invest in?

Sergey Jakimov invests primarily in Health Care, Life Science and Therapeutics startups, most often at Seed stage. Most of the 3 investments tracked by Shizune back companies in Switzerland. The Investment Focus section breaks down every industry, stage and country in the portfolio.

When did Sergey Jakimov last invest?

The most recent investment recorded for Sergey Jakimov closed in Oct 2025. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Sergey Jakimov Sergey Jakimov Find email